Back

Endocarditis-TR: diagnosis, treatment and prognosis of the infective endocarditis patients admitting tertiary centers of Turkey

27 August 2022 (13:15 - 14:00)
Organised by:
Congress Presentation Part of: Aetiology and outcomes in patients with infective endocarditis Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Ali Nazmi Calik

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul (Turkiye)

6 More presentations in this session

Presentation thumbnail
Prevalence and mortality of infective endocarditis among community acquired and healthcare acquired staphylococcus aureus bacteremia: a nationwide study
Doctor L. Ostergaard (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Marantic endocarditis and cancer: diagnosis, treatment and outcomes: a multicentric cohort study
Mr F. Deharo (Marseille, FR)
Abstract Slides
Presentation thumbnail
Prognostic impact of cerebral embolism in patients with active infective endocarditis and therapeutic strategies. A retrospective real world study in a surgical centre.
Doctor S. Menale (Florence, IT)
Abstract Slides
Presentation thumbnail
Outcomes of infective endocarditis in patients with and without pericardial effusion: a National Inpatient Sample study
Doctor R. Cruz Torres (Omaha, US)
Abstract Slides
Presentation thumbnail
Characteristics and outcomes in patients with infective endocarditis caused by Enterococcus faecium and Enterococcus faecalis
Ms I. Try Lenz (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Aetiology and outcomes in patients with infective endocarditis

The Event

Event poster

ESC Congress 2022

27 August 2022 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Evolving trends in infective endocarditis over three decades in a developing country.
27 August 2021
thumbnail
Congress Presentation
1 September 2019
thumbnail
Congress Presentation
Acute and long-term treatment of severe endocarditis.
18 March 2022
thumbnail
Congress Presentation
1 September 2019

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

Lilly Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources